Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1ГБОУ ВПО Ставропольский государственный медицинский университет Минздрава России. 355017, Россия, Ставрополь, ул. Мира, д. 310; 2Университет им. Давида Бен-Гуриона в Негеве. 8410501, Израиль, Беер-Шева
Список исп. литературыСкрыть список 1. Басов А.Н. Тиаприд: терапевтические возможности применения в наркологии, геронтопсихиатрии и при синдроме Туретта. Неврология, нейропсихиатрия, психосоматика. 2013; 3: 64–70. / Basov A.N. Tiaprid: terapevticheskie vozmozhnosti primeneniia v narkologii, gerontopsikhiatrii i pri sindrome Turetta. Nevrologiia, neiropsikhiatriia, psikhosomatika. 2013; 3: 64–70. [in Russian] 2. Гофман А.Г., Крылов Е.Н., Граженский А.В. и др. Сравнительная эффективность препаратов при купировании алкогольного абстинентного синдрома. Новые лекарственные препараты. 2004; 4: 5–6. / Gofman A.G., Krylov E.N., Grazhenskii A.V. i dr. Sravnitel'naia effektivnost' preparatov pri kupirovanii alkogol'nogo abstinentnogo sindroma. Novye lekarstvennye preparaty. 2004; 4: 5–6. [in Russian] 3. Дмитриев А.С., Шевцова Ю.Б., Индин А.С. Подходы к коррекции агрессивного поведения больных алкоголизмом в процессе психофармакотерапии и психотерапии. Рос. психиатр. журн. 2008; 6: 54–62. / Dmitriev A.S., Shevtsova Iu.B., Indin A.S. Podkhody k korrektsii agressivnogo povedeniia bol'nykh alkogolizmom v protsesse psikhofarmakoterapii i psikhoterapii. Ros. psikhiatr. zhurn. 2008; 6: 54–62. [in Russian] 4. Дмитриева Т.Б., Игонин А.Л., Клименко Т.В. и др. Злоупотребление психоактивными веществами. М., 2000. / Dmitrieva T.B., Igonin A.L., Klimenko T.V. i dr. Zloupotreblenie psikhoaktivnymi veshchestvami. M., 2000. [in Russian] 5. Завьялова Н.Е., Салмина-Хвостова О.И. Тиаприд в лечении алкогольного делирия. Рос. психиатр. журн. 2012; 5: 82–7. / Zav'ialova N.E., Salmina-Khvostova O.I. Tiaprid v lechenii alkogol'nogo deliriia. Ros. psikhiatr. zhurn. 2012; 5: 82–7. [in Russian] 6. Индин А.С. Агрессивное поведение у больных алкоголизмом с коморбидными расстройствами личности (факторы риска, клиника, терапия, профилактика). Автореф. … канд. мед. наук. М., 2009. / Indin A.S. Agressivnoe povedenie u bol'nykh alkogolizmom s komorbidnymi rasstroistvami lichnosti (faktory riska, klinika, terapiia, profilaktika). Avtoref. … kand. med. nauk. M., 2009. [in Russian] 7. Поттер-Эфрон Р.Т. Стыд, вина и алкоголизм: клиническая практика. М., 2002. / Potter-Efron R.T. Styd, vina i alkogolizm: klinicheskaia praktika. M., 2002. [in Russian] 8. Салмина-Хвостова О.И., Зяблицев Д.В. Тиаприд в лечении генерализованного тревожного расстройства, коморбидного с алкоголизмом. Рос. психиатр. журн. 2014; 4: 53–7. / Salmina-Khvostova O.I., Ziablitsev D.V. Tiaprid v lechenii generalizovannogo trevozhnogo rasstroistva, komorbidnogo s alkogolizmom. Ros. psikhiatr. zhurn. 2014; 4: 53–7. [in Russian] 9. Сквира И.М. Противорецидивная фармакотерапия алкогольной зависимости (Обзор литературы). Пробл. здоровья и экологии. 2014; 40: 7–11. / Skvira I.M. Protivoretsidivnaia farmakoterapiia alkogol'noi zavisimosti (Obzor literatury). Probl. zdorov'ia i ekologii. 2014; 40: 7–11. [in Russian] 10. Шевцова Ю.Б. Современные методы медикаментозного лечения зависимости от ПАВ. В кн.: Клинические и организационные вопросы наркологии. Под ред. Е.А.Кошкиной. М.: Гениус Медиа, 2011; c. 198–9. / Shevtsova Iu.B. Sovremennye metody medikamentoznogo lecheniia zavisimosti ot PAV. V kn.: Klinicheskie i organizatsionnye voprosy narkologii. Pod red. E.A.Koshkinoi. M.: Genius Media, 2011; c. 198–9. [in Russian] 11. Шмуклер А.Б. Обзор применения тиаприда в современных условиях. Соц. и клин. психиатрия. 2015; 1: 105–8. / Shmukler A.B. Obzor primeneniia tiaprida v sovremennykh usloviiakh. Sots. i klin. psikhiatriia. 2015; 1: 105–8. [in Russian] 12. Agricola R, Mazzarino M, Urani R et al. Treatment of acute alcohol withdrawal syndrome with carbamazepine: a double-blind comparison with tiapride. J Intern Med Res 1982; 10: 60–165. 13. Bayard M, McIntyre J, Hill KR, Woodside J. Alcohol withdrawal syndrome. Am Fam Physician 2004; 69 (6): 1443–550. 14. Bender S, Scherbaum N, Soyka M et al. The efficacy of the dopamine D2/D3-antagonist tiapride in maintaining abstinence: a randomized, double-blind, placebo-controlled trial in 299 alcohol-dependent patients. Int J Neuropsychopharmacol 2007; 10 (5): 653–60. 15. Bourasset G. Tiapride in detoxication of chronic alcoholics (author’s transl). [Article in French]. Sem Hop 1981; 57 (45–46): 1936–37. 16. Cazzato G, Gioseffi M, Torre P et al. Prevention and therapy of delirium tremens with tiapride. [Article in Italian]. Riv Neurol 1982; 52 (6): 379–91. 17. Clavel M, Pommatau E Controlled study of the analgesic efficacy of 2 drugs: tiapride versus aspirin. [Article in French]. Sem Hop 1984; 60 (8): 565–7. 18. Dose M, Lange HW. The benzamide tiapride: treatment of extrapyramidal motor and other clinical syndromes. Pharmacopsychiatry 2000; 33 (1): 19–27. 19. Everitt BJ, Hutcheson DM, Ersche KD et al. The orbital prefrontal cortex and drug addiction in laboratory animals and humans. Ann NY Acad Sci 2007; 1121 (1): 576–97. 20. Hughes K, Anderson Z, Morleo M, Bellis MA. Alcohol, nightlife and violence: The relative contributions of drinking before and during nights out to negative health and criminal outcomes. Addiction 2008; 103: 61–5. 21. Hutchison KE. Alcohol dependence: neuroimaging and the development of translational phenotypes. Alcohol Clin Exp Res 2008; 32 (7): 1111–2. 22. Innamorati M, Tamburello A, Lester D et al. Inequalities in suicide rates in the European Union’s elderly: Trends and impact of macro-socioeconomic factors between 1980 and 2006. Canad J Psychiat 2010; 55: 229–38. 23. Koob GF, Kenneth Lloyd G, Mason BJ. Development of pharmacotherapies for drug addiction: a Rosetta stone approach. Nat Rev Drug Discov 2009; 8 (6): 500–15. 24. Lucht M, Kuehn KU, Armbruster J et al. Alcohol withdrawal treatment in intoxicated vs non-intoxicated patients: a controlled open-label study withtiapride/carbamazepine, clomethiazole and diazepam. Alcohol Alcohol 2003; 38 (2): 168–75. 25. Mainerova B, Prasko J, Latalova K et al. Alcohol withdrawal delirium – diagnosis, course and treatment. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2015; 159 (1): 44–52. 26. Mann K. Pharmacotherapy of alcohol dependence: a review of the clinical data. CNS Drugs 2004; 18 (8): 485–504. 27. Martinez D, Gil R, Slifstein M et al. Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biol Psychiatry 2005; 58 (10): 779–86. 28. Martin-Lopez M, Cano A, Navarro JF. Effects of high doses of sulpiride on agonistic behavior in male mice. Psicothema 1996; 8: 161–6. 29. Martin-Lopez M, Puigcerver A, Vera F, Navarro JF. Sulpiride shows an antiaggressive specific effect after acute treatment in male mice. Med Sci Res 1993; 21: 595–6. 30. Martinotti G, Di Nicola M, Frustaci A et al. Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial. Addiction 2010; 105 (2): 288–99. 31. Mos J, Van Aken HM, Van Oorschot R, Olivier B. Chronic treatment with eltoprazine does not lead to tolerance in its antiaggressive action, in contrast to haloperidol. Eur Neuropsychopharmacol 1996; 6: 1–7. 32. Myrick H, Li X, Randall PK et al. The effect of aripiprazole on cue-induced brain activation and drinking parameters in alcoholics. J Clin Psychopharmacol 2010; 30 (4): 365–72. 33. Navarro JF, Manzaneque JM. Acute and subchronic effects of tiapride on isolation-induced aggression in male mice. Pharmacol Biochem Behav 1997; 58 (1): 255–9. 34. Navarro JF, Minarro J, Simon VM. Daily vs. intermittent haloperidol administration: Effects on social encounters between male mice. Med Sci Res 1992; 20: 531–3. 35. Peters DH, Faulds D. Tiapride. A review of its pharmacology and therapeutic potential in the management of the alcohol dependence syndrome. Drugs 1994; 47 (6): 1010–32. 36. Puech AJ, Lecrubier Y, Simon P. Pharmacological classification of benzamides. Acta Psychiatr Scand Suppl 1984; 311: 139–45. 37. Puech AJ, Simon P, Boissier JR. Benzamides and classical neuroleptics: comparison of their actions using 6 apomorphine-induced effects. Eur J Pharmacol 1978; 50 (4): 291–300. 38. Robert PH, Allain H. Clinical management of agitation in the elderly with tiapride. Eur Psychiatry 2001; 16 (1): 42–7. 39. Scatton B, Cohen C, Perrault G et al. The preclinical pharmacologic profile of tiapride. Eur Psychiatry 2001; 16 (1): 29–34. 40. Shaw GK, Majumdar SK, Waller S et al. Tiapride in the long-term management of alcoholics of anxious or depressive temperament. Br J Psychiatry 1987; 150 (2): 164–8. 41. Shaw GK, Waller S, Majumdar SK et al. Tiapride in the prevention of relapse in recently detoxified alcoholics. Br J Psychiatry 1994; 165 (4): 515–23. 42. Soyka М, Schmidt Р, Franz М et al. Treatment of alcohol withdrawal syndrome with а combiпаtiоп of tiapride/carbamazepine: results of а pooled analysis in 540 patients. Eur Arch Psychiatry Clin Neurosci 2006; 256 (7): 395–401. 43. Steele JW, Faulds D, Sorkin EM. Tiapride. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in geriatric agitation. Drugs Aging 1993; 3 (5): 460–78. 44. Stucker O, Trouvé R, Nahas G. Analgesic effect of tiapride in healthy volunteers. [Article in French]. Encephale 1985; 11 (5): 221–3. 45. Swift R. Medications acting on the dopaminergic system in the treatment of alcoholic patients. Curr Pharm Des 2010; 16 (19): 2136–40. 46. Takeshita N, Ohkubo Y, Yamaguchi I. Tiapride attenuates pain transmission through an indirect activation of central serotonergic mechanism. J Pharmacol Exp Ther 1995; 275 (1): 23–30. 47. Zerhouni O, Begue L, Brousse G et al. Alcohol and violence in the emergency room: a review and perspectives from psychological and social sciences. Int J Environ Res Public Health 2013; 10 (10): 4584–606.